Clean Science and Technology Ltd

In the Q2 FY27 earnings conference call, Clean Science and Technology Limited reported record revenue, driven by volume growth in its base business and the HALS segment, which saw 2x year-on-year revenue growth. Export sales rose to 73% of stand-alone business, and the company achieved 12% EBITDA margins in H1 FY27. However, raw material costs increased to 43.3% of consolidated costs due to high crude-linked feedstock prices, with key materials like phenol and acetone up 50-100% YoY. Despite this, demand remained resilient. On a sequential basis, revenues grew 11% to INR226 crores, with EBITDA and PAT margins at 36% and 24%, respectively. YoY, sales grew 10% with volume stability and realization improvements. Consolidated sales grew 17% year-to-date to INR559 crores. The company highlighted backward integration efforts to reduce costs, including in-house production of intermediates for HALS products. Capital expenditure reached INR900 crores in H1 FY27, with plans to commercialize Performance Chemical 2 by Q4 FY27. The HALS segment is expanding capacity to 12,500 tons, with new advanced grades expected to launch in H2 FY27. Management noted challenges in passing on raw material cost increases to customers due to lower Chinese prices, which limits margin improvement. Capacity utilization for HALS is expected to rise to 55-60% in the coming quarters, though margins remain uncertain due to macroeconomic factors. The company also mentioned a new antioxidant product, Clean Antioxidant 962, with limited production currently.

The document highlights strong revenue growth and operational expansion but also emphasizes cost pressures and margin constraints due to raw material inflation and competitive pricing dynamics.